Expert Interview
Diving into Roche's FENhance 1 Study of fenebrutinib for Relapsing and Primary Progressive Multiple Sclerosis
Ticker(s): RHHBYInstitution: Harvard Medical School
- Associate Professor of Neurology at Harvard Medical School
- Manages 220 patients with MS and most frequently prescribes Ocrevus, Vumerity
- Clinical practice is dedicated to multiple sclerosis and neuromyelitis optica and has published >150 academic manuscripts to advance neurological disease research and clinical care.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
